Blog

An experimental drug from Eli Lilly has the potential to provide greater weight loss benefits than any drug currently on the market. The experimental drug, retatrutide, helped people lose, on average, about 24% of their body weight, the equivalent of about 58 pounds, in a mid-stage clinical trial. This was announced at the American Diabetes Association's annual meeting in San Diego. The findings were also published in The New England Journal of Medicine.

Recover faster with peptide therapy! Here are three game-changing peptides shown to help aid in recovery post-injury or surgery.

Findings about tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) agonist for the treatment of obesity, were presented at ObesityWeek. The study found consistent weight loss regardless of individual factors such as BMI, age, and various comorbidities. This is exciting news for those searching for medical weight loss options, as tirzepatide has shown promise as a useful treatment.  

Fad diets come and go, but many simple "facts" tend to stick around through them all. Here's a look at four popular and persistent ideas around nutrition that are actually myths.